Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Image Credit: Adobe Stock

Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission

New findings identify a new biomarker profile to flag ICU trauma patients at early risk for chronic critical illness. More...
29 Jun 2026
Image: MammaPrint is a 70‑gene expression test that stratifies risk of distant metastasis into UltraLow, Low, High 1, and High 2 categories (photo courtesy of Agendia)

Genomic Assays Predict Anthracycline Benefit in Early-Stage Breast Cancer

A genomic profiling approach predicts anthracycline benefit in HR+/HER2- early breast cancer, optimizing adjuvant selection. More...
29 Jun 2026
Image: Melanoma staging relies on sentinel lymph node biopsy, but most procedures are negative, highlighting the need for tools that better estimate lymph node involvement and avoid unnecessary surgery (Image credit: Adobe Stock)

Gene Expression Test Refines Melanoma Biopsy Decision-Making

An integrated 31‑gene expression result better predicts melanoma sentinel lymph node positivity than nomograms. More...
29 Jun 2026
Image: The large study could support new asthma drug targets, biomarkers, and public health interventions for people most vulnerable to pollution-exacerbated asthma (Image credit: iStock)

Gene Variants Linked to Pollution-Exacerbated Asthma

New findings link oxidative stress gene variants to pollution-related lung decline in asthma, informing biomarkers for risk. More...
29 Jun 2026
Image: Melanoma staging relies on sentinel lymph node biopsy, but most procedures are negative, highlighting the need for tools that better estimate lymph node involvement and avoid unnecessary surgery (Image credit: Adobe Stock)

Gene Expression Test Refines Melanoma Biopsy Decision-Making

An integrated 31‑gene expression result better predicts melanoma sentinel lymph node positivity than nomograms. More...
29 Jun 2026
Image: Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding the company’s pathology portfolio across clinical and research settings

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding its clinical and research pathology portfolio. More...
29 Jun 2026
Image: The planned Bio-Techne acquisition would strengthen Merck KGaA, Darmstadt, Germany, in multi-omics, spatial biology, cell and gene therapy, precision diagnostics, and research tools.

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in fast-growing life sciences markets. More...
29 Jun 2026
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Steam Sterilizer
Hi Vac II Line
Copyright © 2000-2026 Globetech Media. All rights reserved.